Nationwide Fund Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-120,793
Closed -$4.52M 1157
2017
Q3
$4.52M Buy
120,793
+50,431
+72% +$1.72M 0.02% 1064
2017
Q2
$2.2M Buy
70,362
+62,579
+804% +$1.81M 0.01% 1386
2017
Q1
$192K Sell
7,783
-466
-6% -$10.9K ﹤0.01% 2611
2016
Q4
$209K Hold
8,249
﹤0.01% 2581
2016
Q3
$164K Sell
8,249
-1,044
-11% -$18.2K ﹤0.01% 2718
2016
Q2
$133K Buy
9,293
+580
+7% +$8.87K ﹤0.01% 2806
2016
Q1
$135K Hold
8,713
﹤0.01% 2705
2015
Q4
$150K Buy
8,713
+404
+5% +$5.85K ﹤0.01% 2685
2015
Q3
$101K Hold
8,309
﹤0.01% 2894
2015
Q2
$100K Buy
8,309
+7,265
+696% +$71.5K ﹤0.01% 3008
2015
Q1
$9K Hold
1,044
﹤0.01% 3244
2014
Q4
$8K Hold
1,044
﹤0.01% 3165
2014
Q3
$7K Hold
1,044
﹤0.01% 3262
2014
Q2
$9K Hold
1,044
﹤0.01% 3219
2014
Q1
$8K Hold
1,044
﹤0.01% 2966
2013
Q4
$8K Hold
1,044
﹤0.01% 3180
2013
Q3
$7K Hold
1,044
﹤0.01% 3159
2013
Q2
$7K Buy
+1,044
New +$6.58K ﹤0.01% 3150

Other funds holding LMAT

Nationwide Fund Advisors's LMAT Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of LeMaitre Vascular (LMAT) in Q4 2017, closing a stake of 120,793 shares — an estimated $4.52M sold.

Nationwide Fund Advisors first reported a position in LMAT in Q2 2013 and held it in 18 quarters. The position peaked at $4.52M in Q3 2017. 142 funds tracked by Wall St. Rank hold LMAT as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining LeMaitre Vascular position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 120,793 LeMaitre Vascular shares in Q4 2017, an estimated $4.52M.
  • Nationwide Fund Advisors first reported a position in LeMaitre Vascular in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's LeMaitre Vascular position peaked at $4.52M in Q3 2017.
  • 142 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.